Search Results - "Lombrozo, L"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Mesolimbic dopaminergic supersensitivity following electrical kindling of the amygdala by Csernansky, J G, Mellentin, J, Beauclair, L, Lombrozo, L

    Published in Biological psychiatry (1969) (01-02-1988)
    “…Limbic seizures developed in rats following daily electrical stimulation of the basolateral nucleus of the amygdala. Animals were designated as "kindled" after…”
    Get more information
    Journal Article
  2. 2

    Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing by Csernansky, J G, Bellows, E P, Barnes, D E, Lombrozo, L

    Published in Psychopharmacology (01-01-1990)
    “…Recent clinical research suggests that particular patterns of changes in presynaptic dopamine (DA) turnover accompany the therapeutic response to neuroleptics…”
    Get full text
    Journal Article
  3. 3

    Effects of raclopride treatment on plasma and CSF HVA : relationships with clinical improvement in male schizophrenics by CSERNANSKY, J. G, NEWCOMER, J. W, JACKSON, K, LOMBROZO, L, FAULL, K. F, ZIPURSKY, R, PFEFFERBAUM, A, FAUSTMAN, W. O

    Published in Psychopharmacologia (01-11-1994)
    “…Thirty-two acutely psychotic, male schizophrenic patients received raclopride, at 2, 6, or 12 mg/day, or haloperidol, 15 mg/day for 4 weeks after randomized,…”
    Get full text
    Journal Article
  4. 4

    Haloperidol kinetics after oral and intravenous doses by Holley, F O, Magliozzi, J R, Stanski, D R, Lombrozo, L, Hollister, L E

    Published in Clinical pharmacology and therapeutics (01-04-1983)
    “…Haloperidol kinetics were determined after oral and intravenous drug doses in 15 men. Mean elimination t1/2 for the subjects was 17.9 +/- 6.4 (SD) hr. After…”
    Get more information
    Journal Article
  5. 5

    Correlates of rapid neuroleptic response in male patients with schizophrenia by Petrie, E C, Faustman, W O, Moses, J A, Lombrozo, L, Csernansky, J G

    Published in Psychiatry research (01-08-1990)
    “…Correlates of neuroleptic response latency were assessed in 16 male schizophrenic inpatients during 4 weeks of fixed dose (20 mg/day) haloperidol treatment…”
    Get more information
    Journal Article
  6. 6

    A microassay for measuring synaptosomal 3H-dopamine and 3H-metabolite release by Petrie, E C, Lombrozo, L, Csernansky, J G

    Published in Brain research bulletin (01-09-1990)
    “…A modified synaptosomal superfusion apparatus is described which uses less than 10 micrograms of tissue per replicate sample and facilitates the routine…”
    Get more information
    Journal Article
  7. 7

    Interrelationships between plasma homovanillic acid and indices of dopamine turnover in multiple brain areas during haloperidol and saline administration by Csernansky, J G, Barnes, D E, Bellows, E P, Lombrozo, L

    Published in Life sciences (1973) (1990)
    “…Haloperidol or saline was administered to rats daily for 1, 8, 15 or 22 days. During haloperidol, but not saline administration, changes in plasma homovanillic…”
    Get more information
    Journal Article
  8. 8

    Treatment of negative schizophrenic symptoms with alprazolam: a preliminary open-label study by Csernansky, J G, Lombrozo, L, Gulevich, G D, Hollister, L E

    Published in Journal of clinical psychopharmacology (01-12-1984)
    “…Eight schizophrenic patients received alprazolam in an open-label protocol. A partial reversal of negative symptoms was noted in six of the eight patients…”
    Get more information
    Journal Article
  9. 9

    Mood alteration following oral and intravenous haloperidol and relationship to drug concentration in normal subjects by Magliozzi, J R, Gillespie, H, Lombrozo, L, Hollister, L E

    Published in Journal of clinical pharmacology (01-05-1985)
    “…Haloperidol was administered to 12 subjects intravenously (0.125 mg/kg) and to nine subjects orally (0.5 mg/kg). These doses produced sedation in most…”
    Get more information
    Journal Article
  10. 10

    Circadian variations of lorazepam-induced neurologic deficits by Henauer, S, Lombrozo, L, Hollister, L E

    Published in Life sciences (1973) (26-11-1984)
    “…Circadian variations of lorazepam-induced neurologic deficits were tested in mice. The duration of the impairment after administration of 3 mg/kg lorazepam was…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Functional tolerance to alprazolam-induced neurologic deficits in mice by Henauer, S A, Lombrozo, L, Hollister, L E

    Published in Life sciences (1973) (12-11-1984)
    “…Tolerance to alprazolam-induced neurologic deficits was assessed in mice by a rotarod test. Tolerance was found following a second administration of 2 mg/kg…”
    Get more information
    Journal Article
  13. 13

    Plasma concentrations of thiothixene and clinical response in treatment-resistant schizophrenics by Hollister, L E, Lombrozo, L, Huang, C C

    Published in International clinical psychopharmacology (01-01-1987)
    “…Plasma concentrations of thiothixene were measured during treatment of 42 treatment-resistant schizophrenic patients. Inter-individual variability was marked…”
    Get more information
    Journal Article
  14. 14

    Modification of assays for the routine analysis of 3-methoxy-4-hydroxyphenylglycol in urine by electron-capture gas chromatography by Lombrozo, L, Anderson, T J, Kanaske, K, Hollister, L E

    Published in Journal of chromatography (01-01-1980)
    “…Urinary 3-methoxy-4-hydroxyphenylglycol has been reliably assayed on a routine basis using an electron-capture detector method. Modifications of previous…”
    Get more information
    Journal Article
  15. 15
  16. 16

    VI. Separation of cannabinoids by sequential thin layer chromatography by Lombrozo, L, Kanter, S L, Hollister, L E

    “…Using a series of solvent systems, one neutral and non-polar, another basic and a third acidic, in a sequential thin layer chromatography (TLC) scheme we…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19

    Double-blind comparison of alprazolam, diazepam, and placebo for the treatment of negative schizophrenic symptoms by Csernansky, J G, Riney, S J, Lombrozo, L, Overall, J E, Hollister, L E

    Published in Archives of general psychiatry (01-07-1988)
    “…Fifty-five schizophrenic outpatients with negative symptoms were treated for up to six weeks by the addition of alprazolam (mean dose, 4.2 mg/d), diazepam…”
    Get more information
    Journal Article
  20. 20

    Correlation of initial thiothixene serum levels and clinical response. Comparison of fluorometric, gas chromatographic, and RBC assays by Yesavage, J A, Holman, C A, Cohn, R, Lombrozo, L

    Published in Archives of general psychiatry (01-03-1983)
    “…A series of three experiments addressed major problems concerning the use of serum levels as predictors of clinical response to thiothixene (Navane)…”
    Get more information
    Journal Article